Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: <scp>GIDEON</scp> observational study

Masatoshi Kudo; Riccardo Lencioni; Jorge A. Marrero; Alan P. Venook; J.-P. Bronowicki; Xiaoping Chen; Lucy Dagher; Junji Furuse; Jean‐François H. Geschwind; Laura Ladrón de Guevara; Christos N. Papandreou; Arun J. Sanyal; Tadatoshi Takayama; Seung Kew Yoon; Keiko Nakajima; Robert Lehr; Stephanie Heldner; Sheng‐Long Ye

doi:10.1111/liv.13096

Related publications

Article2023

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study

Yu Ki Sim, Ming Chuen Chong, Mihir Gandhi, Yogesh Pokharkar, Yanan Zhu, Luming Shi, Le‐Qun Li, Chien‐Hung Chen, Masatoshi Kudo, Joon Hyeok Lee, Simone I. Strasser, Rawisak Chanwat, Pierce K. H. Chow

Article2016

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON

Jean-François H. Geschwind, Masatoshi Kudo, Jorge A. Marrero, Alan P. Venook, Xiao-Ping Chen, Jean-Pierre Bronowicki, Lucy Dagher, Junji Furuse, Laura Ladrón de Guevara, Christos N. Papandreou, Arun J. Sanyal, Tadatoshi Takayama, Sheng-Long Ye, Seung Kew Yoon, Keiko Nakajima, Robert Lehr, Stephanie Heldner, Riccardo Lencioni

Article2023

Real-world data in 1000 patients with unresectable hepatocellular carcinoma (HCC) treated with systemic therapy: Patient background in PRISM study.

Masafumi Ikeda, Shinji Itoh, Ryosuke Tateishi, Tatsuya Yamashita, Takuji Okusaka, Naoya Kato, Junji Furuse, Masatoshi Kudo

Article2014

OPTIMIS: An international observational study to assess the use of sorafenib after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).

Markus Peck‐Radosavljevic, Jean‐Luc Raoul, Han Chu Lee, Masatoshi Kudo, Keiko Nakajima, Ann‐Lii Cheng

Dataset

Supplementary Material for: Real-world Data on the Diagnosis, Treatment and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT study

Sim Y.K., Chong M.C., Mihir Gandhi, Pokharkar Y.M., Yong‐Guan Zhu, Shi L, Le‐Qun Li, Chen C.-H., Masatoshi Kudo, Lee J.H., Strasser S.I., Rawisak Chanwat, Chow P.K.H., on behalf of the Asia-Pacific Hepatocellular Carcinoma Trials Group